← Browse by Condition
Medical Condition

non small cell adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06810544 Phase 1, Phase 2
Recruiting

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Enrollment
191 pts
Location
United States
Sponsor
Tango Therapeutics, Inc.
View Trial →